A citation-based method for searching scientific literature

Antónia Afonso Póvoa, Elisabete Teixeira, Maria Rosa Bella-Cueto, Rui Batista, Ana Pestana, Miguel Melo, Thalita Alves, Mafalda Pinto, Manuel Sobrinho-Simões, Jorge Maciel, Paula Soares. Cancers (Basel) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prognostic value of p27 in follicular thyroid carcinoma and its relation to radioactive iodine response: does it aid in the modification of risk stratification?
Magdy Hassan Kotb, Ahmed Mohamed Zaher, Mai Amr Abd El-Wahab, Iman Loay Hussein Abulkheir, Manar Hussein, Shahenda Sabry Salem. Appl Immunohistochem Mol Morphol 2014
1
100

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
100

Epithelial-mesenchymal transition and its implications for fibrosis.
Raghu Kalluri, Eric G Neilson. J Clin Invest 2003
100

ER-alpha and ER-beta expression in differentiated thyroid cancer: relation with tumor phenotype across the TNM staging and peri-tumor inflammation.
Flavia Magri, Valentina Capelli, Margherita Gaiti, Laura Villani, Francesca Zerbini, Luigi La Manna, Mario Rotondi, Luca Chiovato. Endocrine 2015
7
100

A central role for cadherin signaling in cancer.
Antonis Kourtidis, Ruifeng Lu, Lindy J Pence, Panos Z Anastasiadis. Exp Cell Res 2017
116
100

Molecular mechanisms of blood vessel growth.
E M Conway, D Collen, P Carmeliet. Cardiovasc Res 2001
665
100


P53 and expression of immunological markers may identify early stage thyroid tumors.
Marjory Alana Marcello, Elaine Cristina Morari, Lucas Leite Cunha, Aline Carolina De Nadai Silva, Dirce Maria Carraro, André Lopes Carvalho, Fernando Augusto Soares, José Vassallo, Laura Sterian Ward. Clin Dev Immunol 2013
15
100

Survivin: A molecular biomarker in cancer.
Praveen Kumar Jaiswal, Apul Goel, R D Mittal. Indian J Med Res 2015
151
100

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.
Nikhil Gupta, Anil K Dasyam, Sally E Carty, Marina N Nikiforova, N Paul Ohori, Michaele Armstrong, Linwah Yip, Shane O LeBeau, Kelly L McCoy, Christopher Coyne,[...]. J Clin Endocrinol Metab 2013
98
100

RAS mutations in thyroid cancer.
Gina M Howell, Steven P Hodak, Linwah Yip. Oncologist 2013
104
100

Prognostic value of oncoprotein expressions in thyroid papillary carcinoma.
A Z Balta, A I Filiz, Y Kurt, I Sucullu, E Yucel, M L Akin. Med Oncol 2012
19
100

BRAF-mutated carcinomas among thyroid nodules with prior indeterminate FNA report: a systematic review and meta-analysis.
Pierpaolo Trimboli, Giorgio Treglia, Emma Condorelli, Francesco Romanelli, Anna Crescenzi, Massimo Bongiovanni, Luca Giovanella. Clin Endocrinol (Oxf) 2016
34
100

BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.
Fei Li, Guangqi Chen, Chunjun Sheng, Aaron M Gusdon, Yueye Huang, Zhongwei Lv, Huixiong Xu, Mingzhao Xing, Shen Qu. Endocr Relat Cancer 2015
72
100

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression.
Brian Keith, Randall S Johnson, M Celeste Simon. Nat Rev Cancer 2011
100


Estrogen and cancer.
Jing Liang, Yongfeng Shang. Annu Rev Physiol 2013
139
100

Application of immunohistochemistry in thyroid pathology.
Haiyan Liu, Fan Lin. Arch Pathol Lab Med 2015
40
100

A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma.
Huy Gia Vuong, Uyen N P Duong, Ahmed M A Altibi, Hanh T T Ngo, Thong Quang Pham, Hung Minh Tran, Greta Gandolfi, Lewis Hassell. Endocr Connect 2017
37
100

Evaluation of MMP2 and Caspase-3 expression in 107 cases of papillary thyroid carcinoma and its association with prognostic factors.
Hiva Saffar, Sanaz Sanii, Binesh Emami, Ramin Heshmat, Vahid Hagh Panah, Sima Azimi, Seyed Mohammad Tavangar. Pathol Res Pract 2013
18
100


CD44 as a tumor biomarker and therapeutic target.
Hanxiao Xu, Mengke Niu, Xun Yuan, Kongming Wu, Aiguo Liu. Exp Hematol Oncol 2020
22
100

Estrogen and its receptors in cancer.
George G Chen, Qiang Zeng, Gary Mk Tse. Med Res Rev 2008
133
100

BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.
Guillaume Gauchotte, Christophe Philippe, Stéphanie Lacomme, Brigitte Léotard, Marie-Pierre Wissler, Lila Allou, Bruno Toussaint, Marc Klein, Jean-Michel Vignaud, Aude Bressenot. Pathology 2011
38
100

Clinical prognostic significance of cancer stem cell markers in patients with papillary thyroid carcinoma.
Yoon-Jong Ryu, Ji-Young Choe, Kyoungyul Lee, Soon-Hyun Ahn. Oncol Lett 2020
4
100

p27 as Jekyll and Hyde: regulation of cell cycle and cell motility.
Michelle D Larrea, Seth A Wander, Joyce M Slingerland. Cell Cycle 2009
107
100


Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, David Viola, Rossella Elisei, Bela Bendlova, Linwah Yip, Caterina Mian, Federica Vianello, R Michael Tuttle,[...]. JAMA 2013
549
100

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.
Cristina Romei, Rossella Elisei. Front Endocrinol (Lausanne) 2012
79
100

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.
R K Moyzis, J M Buckingham, L S Cram, M Dani, L L Deaven, M D Jones, J Meyne, R L Ratliff, J R Wu. Proc Natl Acad Sci U S A 1988
100



BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
Carol Li, Kathleen C Lee, Eric B Schneider, Martha A Zeiger. J Clin Endocrinol Metab 2012
166
100

Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause.
Gustavo A Rubio, Paola Catanuto, Marilyn K Glassberg, John I Lew, Sharon J Elliot. Surgery 2018
14
100

BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.
Anna Guerra, Vincenzo Marotta, Maurilio Deandrea, Manuela Motta, Paolo Piero Limone, Alessia Caleo, Pio Zeppa, Silvano Esposito, Franco Fulciniti, Mario Vitale. Endocrine 2013
25
100


VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis.
Andrew V Benest, Steven J Harper, Seppo Yla Herttuala, Kari Alitalo, David O Bates. Cardiovasc Res 2008
57
100


Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?
Erik W Thompson, Donald F Newgreen, David Tarin. Cancer Res 2005
506
100

Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer.
George G Chen, Alexander C Vlantis, Qiang Zeng, C Andrew van Hasselt. Curr Cancer Drug Targets 2008
105
100

HIF-1α pathway: role, regulation and intervention for cancer therapy.
Georgina N Masoud, Wei Li. Acta Pharm Sin B 2015
743
100

Immunohistochemical expression and prognostic significance of VEGF-C in well-differentiated thyroid cancer.
S Ceric, T Ceric, N Pojskic, N Bilalovic, J Musanovic, E Kucukalic-Selimovic. Acta Endocrinol (Buchar) 2020
1
100

Regulation of the cdk inhibitor p27 and its deregulation in cancer.
J Slingerland, M Pagano. J Cell Physiol 2000
579
100


Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
Maria E Cabanillas, Mabel Ryder, Camilo Jimenez. Endocr Rev 2019
63
100

Cyclin D1, Ret and P27 Expression in Papillary Thyroid Microcarcinoma
Ana Barić, Vinko Marković, Davor Eterović, Vladimir Bedeković, Mirko Kontić, Ljubica Juretić Kuščić, Valdi Pešutić Pisac, Ante Punda. Acta Clin Croat 2017
3
100


The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers.
Giuseppe Pannone, Angela Santoro, Daniela Pasquali, Rosanna Zamparese, Marilena Mattoni, Giuseppe Russo, Matteo Landriscina, Annamaria Piscazzi, Paolo Toti, Mauro Cignarelli,[...]. Thyroid 2014
25
100

Prognostic and Therapeutic Role of Angiogenic Microenvironment in Thyroid Cancer.
Assunta Melaccio, Lucia Ilaria Sgaramella, Alessandro Pasculli, Giovanna Di Meo, Angela Gurrado, Francesco Paolo Prete, Angelo Vacca, Roberto Ria, Mario Testini. Cancers (Basel) 2021
2
100

The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
Maryam Zarkesh, Azita Zadeh-Vakili, Mahdi Akbarzadeh, S Ahmad Fanaei, Mehdi Hedayati, Fereidoun Azizi. BMC Cancer 2018
12
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.